Quantcast
Last updated on April 24, 2014 at 16:36 EDT

Latest Stem cells Stories

2014-02-13 10:35:34

Cancer researchers led by stem cell scientist Dr. John Dick have discovered a pre-leukemic stem cell that may be the first step in initiating disease and also the culprit that evades therapy and triggers relapse in patients with acute myeloid leukemia (AML). The research, published online today in Nature is a significant leap in understanding the steps that a normal cell has to go through as it turns into AML, says Dr. Dick, and sets the stage to advance personalized cancer medicine by...

2014-02-13 08:29:59

GREENWOOD VILLAGE, Colo., Feb. 13, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced preliminary biochemical analysis of samples of synovial fluid drawn from the index knee (treated knee) of a subset of patients who participated in the SPRING study. This synovial analysis, suggested by the FDA, tests the change in expression of signaling and structural proteins that arise from the treatment of the knee with either Ampion(TM) or the saline vehicle...

2014-02-12 23:26:19

Stemedica announced today that Richard Mejia, Jr. has joined the Company’s Board of Directors and will be Chairman of the Company’s Audit Committee effective February 11, 2014. San Diego, CA (PRWEB) February 12, 2014 Stemedica announced today that Richard Mejia, Jr. has joined the Company’s Board of Directors and will be Chairman of the Company’s Audit Committee effective January 31, 2014. Mr. Mejia spent 38 years with Ernst & Young, LLP where he was a partner for 25 years. He...

2014-02-12 23:02:06

Join Miami Stem Cell Treatment Center on an exciting educational seminar focusing on how adipose-derived stem cells have been shown to have a preferred differentiation capability, have a minimal and virtually painless ease of extraction, and have been scientifically proven to have strong immuno-modulatory effects. Boca Raton, FL (PRWEB) February 12, 2014 The Miami Stem Cell Treatment Center, PC, located in Miami, Ft. Lauderdale, and Boca Raton, Florida, announces a series of free public...

2014-02-12 12:31:06

LONDON, Feb. 12, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Translational Regenerative Medicine: Market Prospects 2014-2024Report DetailsOur new study shows you the commercial potential of regenerative treatmentsWhat does the future hold for regenerative medicine? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.Our study lets you assess regenerative medicine: cell-based...

2014-02-12 12:30:25

As Stem Cells from the Umbilical Cord and Placenta Tissue Become More Important, Americord Attracts A New Set of Savvy Customers NEW YORK, Feb. 12, 2014 /PRNewswire/ -- As the scientific community moves forward with ever more therapeutic uses for hematopoietic stem cells and pursues revolutionary medical possibilities for mesenchymal stem cells, expectant parents are increasingly understanding the value of preserving stem cells from not only the cord blood, but also the cord tissue...

2014-02-12 08:28:38

ST. LOUIS, Feb. 12, 2014 /PRNewswire/ -- ISTO Technologies, Inc., a privately-held regenerative medicine company, announced today that Mitchell Seyedin, Ph.D., the Company's Executive Chairman, will present at the New York Stem Cell Summit 2014. -- Date: Tuesday, February 18, 2014, -- Venue: The Convene, Downtown, New York, New York -- Session Time: 11:55 AM EST -- Session Topic: Practical Methods for Combining Cells and Tissue Engineering About ISTO...

2014-02-11 23:21:22

Autologous Cell Therapy Market reserach report gives a detailed analysis about state of the art of both autologous stem cell and non-stem cell treatments. http://www.marketsandmarkets.com/Market-Reports/autologous-cell-therapy-market-837.html (PRWEB) February 11, 2014 The report “Autologous Cell Therapy (ACT) Market (2012 - 2017)”, would be the first global and exclusive report on ACT market. It also gives clear information about the complete industry, approved products and potential...

2014-02-11 08:33:38

StemGenex is now providing access to its latest stem cell therapy for patients diagnosed with COPD through nebulized stem cells. These treatments are being studied with expertise by board certified MD's in the United States. LA JOLLA, Calif., Feb. 11, 2014 /PRNewswire/ -- StemGenex®, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases, today announced the newest therapy to assist patients...

2014-02-10 08:28:04

DUBLIN, Feb. 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/vsrgks/cord_blood ) has announced the addition of the "Cord Blood Banking Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Stem cells are capable of producing all the three types of blood cells produced in human body i.e. red blood cells, platelets and...